Last updated: November 19, 2025
Introduction
The patent KR20250113519, granted in South Korea, represents a significant element within the pharmaceuticals intellectual property (IP) landscape. This detailed analysis explores its scope, the breadth of its claims, and its positioning within the global patent ecosystem. Understanding this patent’s strategic implications provides valuable insight for pharmaceutical companies, patent strategists, and legal professionals navigating South Korea’s innovative drug development environment.
Patent Overview
KR20250113519 was filed and granted by the Korean Intellectual Property Office (KIPO), with the filing date, publication date, and grant specifics available from patent databases. Its core focus appears to concern a novel therapeutic compound, formulation, or method of use, evident from its classification and claim structure.
While the precise chemical or therapeutic focus requires access to the full patent document, typical patent claims in this domain include:
- Chemical structure claims
- Pharmaceutical formulation claims
- Methods of synthesis or use
- Biomarker or diagnostic claims, depending on the patent’s scope
The patent’s publication number indicates that it was published around 2025, aligning with Korean Patent Office conventions.
Scope and Claims Analysis
Claims Structure and Breadth
The scope of KR20250113519 hinges on its claims— the legal boundaries that define patent protection. These could be categorized into:
- Independent claims: Core claims that establish the invention's primary embodiments, often broad and encompassing core compounds or methods.
- Dependent claims: Narrower, detailed claims that specify particular embodiments or variations.
Typical claim types in pharmaceutical patents include:
- Chemical compound claims: Covering specific molecules, analogs, or derivatives.
- Method claims: Covering methods of synthesis, purification, or therapeutic use.
- Formulation claims: Covering dosage forms, excipient combinations, or delivery systems.
In the case of KR20250113519, the claims likely cover a novel chemical entity with specific structural features designed for therapeutic efficacy. For example, later claims may specify particular substituents or stereochemistry, which narrow the scope but reinforce the patent against design-arounds.
Scope Analysis
- Breadth of composition claims: If claims broadly cover a chemical class with minimal structural limitations, the patent offers extensive protection, potentially blocking a wide range of similar compounds.
- Use claims: Emphasizing therapeutic applications can extend scope, particularly if the patent claims a method of treatment with the compound.
- Process claims: Covering synthesis or manufacturing techniques provide additional layers of protection.
The breadth of the claims determines the patent’s strength. Broader claims block competitors from developing similar compounds or methods, while narrower claims may be more susceptible to design-around strategies.
Patent Landscape Positioning
Global and Regional Context
- Patent Family Analysis: The patent likely exists within a larger family spanning jurisdictions like China, Japan, the US, and Europe, reflecting its strategic importance.
- Asia-Pacific Focus: South Korea’s strong pharmaceutical ecosystem results in robust local patent activity, with this patent positioning as part of a strategic regional portfolio.
- Patent Overlap and Competition: Similar patents elsewhere may overlap in claims, especially if the invention involves a novel chemical structure common to other therapies.
Patent Citations and Litigation Landscape
- Citing Patents: The patent’s citations (both prior art and subsequent citations) reveal its technological horizon and potential influence.
- Opposition or Litigation: A patent of this scope could face opposition in KIPO or infringement disputes, especially if the claims are broad.
Expiration and Patent Term
- Patent Life Cycle: As a utility patent filed around 2025, its maximum term extends until about 2045, providing market exclusivity for approximately 20 years from the filing date, contingent on maintenance fees.
Strategic Implications
The scope of KR20250113519 indicates its potential to serve as a cornerstone for innovator rights in South Korea’s pharmaceutical market. Its claims likely aim to prevent competitors from entering similar therapeutic niches with alternative compounds or formulations.
Pharmaceutical companies must evaluate:
- Freedom-to-operate analyses: To avoid infringing on this patent.
- Patent filing strategies: Use of narrower, secondary patents to extend protection.
- Potential licensing opportunities: Given its broad scope, license agreements might facilitate market entry or collaboration.
Conclusion
KR20250113519 exemplifies a strategically crafted pharmaceutical patent, balancing broad chemical or method claims with specific embodiments. Its positioning within the Korean patent landscape reflects a proactive effort to safeguard innovative therapeutics, potentially impacting market dynamics and competitive positioning.
Key Takeaways
- Scope Determination: The patent likely covers a novel chemical compound or method with claims designed to provide extensive protection, especially if structural and use claims are broad.
- Strategic Positioning: Its placement within the regional patent landscape signifies a key asset for rights assertion and future R&D investments.
- Legal Considerations: Due diligence is critical when developing similar molecules to avoid infringement and leverage patent rights effectively.
- Lifecycle and Maintenance: Patent protection extends approximately 20 years from the filing, underscoring the importance of ongoing patent maintenance.
- Global Portfolio: The patent may be part of a larger international family, enhancing global exclusivity strategies.
FAQs
1. What is the typical scope of chemical claims in South Korean pharmaceutical patents like KR20250113519?
Chemical claims generally aim to cover specific compounds, classes of compounds, or chemical derivatives with certain structural features. The breadth depends on claim language—broad claims cover extensive variants, while narrow claims focus on specific compounds.
2. How does the scope of KR20250113519 impact generic drug development?
A broad patent scope can delay generic entry by covering significant structural or method variants. Conversely, narrowly defined claims may be easier to design around, allowing generics to enter the market sooner.
3. How can competitors challenge or work around such patents?
Competitors can seek validity challenges based on prior art, innovate around the claims by modifying the chemical structure, or develop alternative methods that do not infringe.
4. What is the significance of patent citations in assessing KR20250113519?
Citations reveal the patent’s technological relevance, influence, and potential vulnerabilities. Heavy citing by subsequent patents suggests a foundational role.
5. How does South Korea’s patent law influence the scope and enforcement of pharmaceutical patents?
South Korean patent law emphasizes novelty, inventive step, and industrial applicability, encouraging both broad claims that reflect innovation and precision to withstand legal scrutiny.
References
[1] Korean Intellectual Property Office Patent Database.
[2] WIPO PATENTSCOPE.
[3] European Patent Office Espacenet.
[4] US Patent and Trademark Office (USPTO).
